scispace - formally typeset
J

Jeremy J. Davis

Researcher at University of Utah

Publications -  34
Citations -  816

Jeremy J. Davis is an academic researcher from University of Utah. The author has contributed to research in topics: Test validity & Test of Memory Malingering. The author has an hindex of 13, co-authored 30 publications receiving 686 citations. Previous affiliations of Jeremy J. Davis include Indiana University & Rehabilitation Institute of Michigan.

Papers
More filters
Journal ArticleDOI

Identification of blood biomarkers for psychosis using convergent functional genomics

TL;DR: Predictive scores show good sensitivity and negative predictive value for detecting high psychosis states in the original cohort as well as in three additional cohorts, with implications for the development of objective laboratory tests to measure illness severity and response to treatment in devastating disorders such as schizophrenia.
Journal ArticleDOI

Examination of Performance Validity Test Failure in Relation to Number of Tests Administered

TL;DR: The relationship among performance validity test (PVT) failure, number of PVTs administered, and participant characteristics including demographic, diagnostic, functional, and contextual factors in a clinical sample of outpatient physiatry referrals is examined.
Journal ArticleDOI

Treatment adherence in cognitive processing therapy for combat-related PTSD with history of mild TBI.

TL;DR: Findings suggest that standard CPT for PTSD may be a tolerable treatment for OEF/OIF veterans with a history of PTSD and mTBI as well as veterans with PTSD alone.
Journal ArticleDOI

The Medical Symptom Validity Test in the evaluation of Operation Iraqi Freedom/Operation Enduring Freedom soldiers: a preliminary study.

TL;DR: Preliminary findings and additional test data supported the conclusion that participants who failed the Medical Symptom Validity Test were exhibiting diminished symptom validity, suggesting that the specificity of the MSVT was 100%.
Journal ArticleDOI

Utility of the response bias scale (RBS) and other MMPI-2 validity scales in predicting TOMM performance.

TL;DR: Results of the current study confirm the clinical utility of the RBS and suggest that, particularly if the MMPI-2 is an existing part of the neuropsychological assessment, examination of RBS scores is an efficient means of detecting negative response bias.